BalazsHalmosMD

PubMed

• Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
  Owen, D. H., Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Shirish Gadgeel, Gregory Masters, Erin L Schenk, Bryan J Schneider...> ;Journal of Clinical Oncology. 2024 Apr 10
• Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.
  Owen, D. H., Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Shirish Gadgeel, Gregory Masters, Erin L Schenk, Bryan J Schneider...> ;Journal of Clinical Oncology. 2024 Apr 10
• Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors.
  Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao V Alessi, Adriana Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di ...> ;Cancer Discovery. 2024 Apr 3
• Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemo...
  Luis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, Balazs Halmos, Byoung Chul Cho, Manuel Cobo, José Luis González Larriba, Caicun Zhou, Ingel Demedts, Akin Atmaca, Sof...> ;Lung Cancer. 2024 Mar 1
• Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New Challenges.
  Angelica D'Aiello, Brendon Stiles, Nitin Ohri, Benjamin Levy, Perry Cohen, Balazs Halmos> ;Clinical Lung Cancer. 2024 Feb 13
• Influence ofComutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in-Mutant Non-Small-Cell Lung Cancer.
  Naqash, A., Floudas, C., Aber, E., Maoz, A., Nassar, A., Adib, E., Choucair, K., Xiu, J., Baca, Y., Ricciuti, B., Alessi, J., Awad, M., Kim, C., Judd, J., Raez, L., Lo...> ;JCO Precision Oncology. 2024 Feb 1
• Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research.
  Vidal, G., Chalela, P., Curry, A., El-Rayes, B., Halmos, B., Herrera, A., Kapoor, K., Kaur, S., Mahadevan, D., Mesa, R., Ramirez, A., Sleckman, B., Wagner, A., Bhagat,...> ;Contemporary Clinical Trials. 2024 Feb 1
• 1 citations
  HIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune Biomarkers Impacting Lung Cancer Screening and Management.
  Ayse Ece Cali Daylan, Catarina Martins Maia, Shirin Attarian, Xiaoling Guo, Mindy Ginsberg, Enrico Castellucci, Rasim Gucalp, Missak Haigentz, Balazs Halmos, Haiying C...> ;Clinical Lung Cancer. 2024 Mar 1
• Similar Efficacy Observed for First-Line Immunotherapy in Racial/Ethnic Minority Patients With Metastatic NSCLC.
  Matthew Lee, Jianyou Liu, Emily Miao, Shuai Wang, Frank Zhang, John Wei, Julie Chung, Xiaonan Xue, Balazs Halmos, H Dean Hosgood, Haiying Cheng> ;Journal of the National Comprehensive Cancer Network. 2023 Dec 1
• 1 citations
  Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).
  Nitin Ohri, Shruti Jolly, Benjamin T Cooper, Rafi Kabarriti, William R Bodner, Jonathan Klein, Chandan Guha, Shankar Viswanathan, Elaine Shum, Joshua K Sabari, Haiying...> ;Journal of Clinical Oncology. 2024 Feb 10
• Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
  Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, Melina E Marmarelis, Carolyn J Presley, Karen L Reckamp, Hina Khan, Mary Jo Fidler, Christine M Bestvina, Julie Brahm...> ;Lung Cancer. 2023 Dec 1
• Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail.
  Ayse Ece Cali Daylan, Balazs Halmos> ;Translational Lung Cancer Research. 2023 Jul 31
• 2 citations
  Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset.
  Misako Nagasaka, Danielle Brazel, Yasmine Baca, Joanne Xiu, Mohammed Najeeb Al-Hallak, Chul Kim, Jorge Nieva, Jeffrey J Swensen, David Spetzler, Wolfgang Michael Korn,...> ;Translational Oncology. 2023 Oct 1
• Cancer rarely travels alone: Addressing the accumulation of risk and early mortality for older adults with advanced lung cancer.
  Carolyn J Presley, Megan Baumgart, Balazs Halmos, Efrat Dotan> ;Journal of Geriatric Oncology. 2023 Jul 8
• 1 citations
  Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer.
  Michael Pennock, Balazs Halmos, William Bodner, Haiying Cheng, Rasim Gucalp, Nitin Ohri> ;Clinical and Translational Radiation Oncology. 2023 Jul 1
• 2 citations
  Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways.
  Feng Wang, Ayse Ece Cali Daylan, Lei Deng, Jihua Yang, Janaki Sharma, Christopher Su, Shenduo Li, Xingxing Zang, Balazs Halmos, Alain Borczuk, Haiying Cheng> ;Cancers. 2023 Jun 27
• Orthogonal Testing Unravels a Novel ROS1 Oncogenic Fusion Variant (): A Practical Approach to Molecular Testing for Actionable Fusion Variants.
  Hiba G Narvel, So Yeon Kim, Aspan M Shokrekhuda, Perry R Cohen, K H Ramesh, Sheila R Solomon, Paul K Paik, Balazs Halmos> ;JCO Precision Oncology. 2023 Apr 1
• 5 citations
  Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial.
  Astha Thakkar, Kith Pradhan, Benjamin Duva, Juan Manuel Carreno, Srabani Sahu, Victor Thiruthuvanathan, Sean Campbell, Sonia Gallego, Tushar D Bhagat, Johanna Rivera, ...> ;Elife. 2023 Mar 28
• 1 citations
  Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study.
  Melissa L Johnson, James Strauss, Manish R Patel, Edward B Garon, Keith D Eaton, Tavette Neskorik, Josée Morin, Richard Chao, Balazs Halmos> ;Clinical Lung Cancer. 2023 May 1
• 57 citations
  Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
  Silvia Novello, Dariusz M Kowalski, Alexander Luft, Mahmut Gümüş, David Vicente, Julien Mazières, Jeronimo Rodríguez-Cid, Ali Tafreshi, Ying Cheng, Ki Hyeong Lee, Alex...> ;Journal of Clinical Oncology. 2023 Apr 10
• 10 citations
  Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC.
  Marina C Garassino, Shirish Gadgeel, Silvia Novello, Balazs Halmos, Enriqueta Felip, Giovanna Speranza, Rina Hui, Edward B Garon, Hidehito Horinouchi, Shunichi Sugawar...> ;JTO Clinical and Research Reports. 2023 Jan 1
• 1 citations
  Emerging Biomarkers in Immune Oncology to Guide Lung Cancer Management.
  Houssein Safa, Fawzi Abu Rous, Neel Belani, Hossein Borghaei, Shirish Gadgeel, Balazs Halmos> ;Targeted Oncology. 2023 Jan 1
• Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.
  Lindsay M Gurska, Rachel Okabe, Alexandra Schurer, Meng Maxine Tong, Mark Soto, Daniel Choi, Kristina Ames, Shira Glushakow-Smith, Allison Montoya, Ellen Tein, Linde A...> ;Clinical Cancer Research. 2023 Mar 1
• Use of Erdafitinib in-Mutated Recurrent Respiratory Papillomatosis.
  Vincent Yeung, Paul Sackstein, Nazaneen N Grant, Rebecca Krochmal, Nishant Gandhi, Charu Aggarwal, Balazs Halmos, Joshua E Reuss, Stephen V Liu, Chul Kim> ;JCO Precision Oncology. 2022 Nov 1
• 1 citations
  Prevalence and Assessment of Factors Associated with COVID-19 Vaccine Hesitancy in an Ethnic Minority Oncology Patient Population.
  Matthew Lee, Emily Miao, Bruce Rapkin, Balazs Halmos, Viswanathan Shankar, Sanjay Goel> ;Vaccines. 2022 Oct 14
• Join now to see all

Journal Articles

• Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer  
  Balazs Halmos, MD, The New England Journal of Medicine